An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients with Chronic Kidney Disease

Administered By

Pediatrics, Nephrology

Awarded By

Reata Pharmaceuticals, Inc.

Contributors

Gbadegesin, Rasheed Adebayo Principal Investigator

Start/End

August 5, 2021 - August 4, 2023